ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:
| 1. | Details of the person discharging managerial responsibility / person closely associated | ||
| a) | Name | Carsten Hellmann | |
| 2. | Reason for the notification | ||
| a) | Position/status | President & CEO | |
| b) | Initial notification/ amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | ALK-Abelló A/S | |
| b) | LEI | 529900SGCREUZCZ7P020 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Share options DK0060027142 | |
| b) | Nature of the transaction | Purchase (exercise of share options) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 15,770,832 | 17,068 | ||
| d) | Aggregated information - Aggregated volume - Price | 17,068 DKK 15,770,832 | |
| e) | Date of the transaction | 2021-02-19 | |
| f) | Place of the transaction | Nasdaq Copenhagen | |
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, mobile +45 2261 2525
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Columbus A/S7.11.2025 23:46:30 CET | Press release
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Evaxion7.11.2025 23:10:00 CET | Press release
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
VALLOUREC7.11.2025 18:45:00 CET | Press release
VALLOUREC ANNOUNCES A TRANSITION IN ITS FINANCIAL MANAGEMENT
Trifork Group AG7.11.2025 18:29:08 CET | Press release
52/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
